CD22-directed Immunoconjugate

Name
CD22-directed Immunoconjugate
Accession Number
DBCAT003836
Description

Not Available

Drugs
DrugDrug Description
Inotuzumab ozogamicinAn antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL).
Drugs & Drug Targets
DrugTargetType
Inotuzumab ozogamicinP-glycoprotein 1transporter
Inotuzumab ozogamicinB-cell receptor CD22target